Fitzgerald Kevin Joseph sold ALNY
November 17, 2025 · Form 4 insider transaction
Fitzgerald Kevin Joseph sold 8,168 shares of Alnylam Pharmaceuticals, Inc. at $449.00 per share, a transaction worth $3.67M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
8,168
Price
$449.00
Total value
$3.67M
InsiderFitzgerald Kevin Joseph
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 17, 2025
Filing dateNovember 19, 2025
Shares owned after25,224
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the Reporting Person on August 14, 2025.